Skip to main content
. 2019 Apr 23;17(6):4715–4722. doi: 10.3892/etm.2019.7521

Figure 1.

Figure 1.

Upregulation of DLX6-AS1 in gastric cancer. (A) DLX6-AS1 expression is significantly increased in gastric cancer tissues compared with adjacent normal tissues, as determined via reverse transcription-quantitative PCR. **P<0.01 vs. Adjacent. (B) The expression of DLX6-AS1 was higher in advanced gastric cancer tissue samples (III/IV) compared with early-stage samples (I/II). **P<0.01 vs. Stage I/II. (C) Patients with gastric cancer and a high DLX6-AS1 expression exhibited shorter survival time than those with a lower expression of DLX6-AS1. (D) DLX6-AS1 expression was significantly higher in gastric cancer cell lines than in the GES-1 cell line. **P<0.01 vs. GES-1. DLX6-AS1, distal-less homeobox 6 antisense 1.